Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Artrya collaborates with healthcare facilities that treat chest pain patients to introduce innovative cardiovascular care models powered by artificial intelligence. This approach seamlessly incorporates high-prognostic plaque characteristics into the assessment of coronary artery disease. It enables swift evaluations of chest pain patients in both emergency and primary care environments. Our vision is a society free from the burden of heart attacks. Leveraging AI-generated insights from coronary computed tomography angiography (CCTA), we can rapidly and accurately classify chest pain patients based on the type and quantity of arterial plaque identified. This allows for quick identification of individuals with little to no coronary artery disease, ensuring that no underlying plaque issues could lead to significant cardiac events in the future. By recognizing early indicators of potential heart attacks, we can effectively confirm at-risk patients with acute or unusual chest pain who may require additional investigation and treatment. Ultimately, this advancement aims to enhance patient outcomes and foster a healthier community.
Description
Our extensive range of products encompasses VNA, PACS systems, Radiology Information Systems (RIS), Diagnostic Viewers, and AI-driven Medical Diagnostic Support Solutions (MDSS) tailored for applications such as MMG, CT chest, ECG, and endoprosthesis imaging via X-ray. With over 300,000 active users each month and 20,000 units of diagnostic equipment seamlessly integrated with our PACS|VNA, we are proud to provide cutting-edge technological solutions designed to enhance patient care. We are eager to share our expertise in healthcare digitalization, aimed at enriching the lives of patients through improved diagnostic processes. Our commitment extends to facilitating the adoption of our solutions to streamline workflows for end users, including radiologists, oncologists, and cardiologists. Drawing on 14 years of experience collaborating with 5,000 clinics, we have developed core competencies that support a comprehensive and modular platform for the entire imaging process, independent of vendor constraints. Additionally, our AI-based medical decision support systems are designed to efficiently prioritize cases with pathologies on a single screen, utilizing a red-yellow-green alert system to enhance clinical decision-making. This innovative approach ensures that healthcare providers can focus on what truly matters: delivering exceptional patient care.
API Access
Has API
API Access
Has API
Screenshots View All
No images available
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
$1000
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Artrya
Country
Australia
Website
www.artrya.com
Vendor Details
Company Name
ROKAPAX
Founded
2010
Country
Cyprus
Website
www.rokapax.com
Product Features
Product Features
Radiology
Audit Trail
Billing & Invoicing
Claims Management
EDI
EMR HL7 Bridge
Image Fusion
PACS Integration
Patient Scheduling
Scanning Input
Teleradiology
Wait List Management